Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05885542 · ClinicalTrials.gov registry record · Phase 1
SCORE Emerging Adult Cannabis Use & Stress
A Phase 1 study of Cannabis Use Disorder, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 148
- Enrollment target
- 1
- Study location
NCT05885542: Recruiting Phase 1 study of Cannabis Use Disorder, sponsored by Medical University of South Carolina.
NCT05885542 is a Phase 1 study of Cannabis Use Disorder that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 148 participants, above the 105-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (41% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05885542, a Phase 1 study of Cannabis Use Disorder, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
The interface between cannabis use and stress is a particularly important focus for sex differences research in emerging adults. Given the dynamics at play in this critical stage when cannabis use is most prevalent, developmentally informed research is needed to guide tailored clinical interventions. This study will apply rigorous and innovative methods to elucidate sex differences in the nexus of cannabis use and stress among emerging adults with cannabis use disorder to guide the development of tailored treatments.
Primary Outcome
Cannabis Withdrawal Scale score (Allsop et al., 2011) \[minimum score 0 and maximum score 190; higher score means a worse outcome\]
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Cannabidiol oral solution
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2028-07-31 |
| Phase | Phase 1 |
What NCT05885542 shows while recruiting
NCT05885542 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, above the 105-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (41% higher).
The record links to 1 condition, with Cannabis Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05885542 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05885542 about?
NCT05885542 is a clinical study titled "SCORE Emerging Adult Cannabis Use & Stress". The interface between cannabis use and stress is a particularly important focus for sex differences research in emerging adults. Given the dynamics at play in this critical stage when cannabis use is most prevalent, developmentally informed research is needed to guide tailored clinical interventions...
What is the current status of trial NCT05885542?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 148 participants. The study started on 2023-11-01. Estimated completion is 2028-07-31.
What conditions does trial NCT05885542 study?
This clinical trial studies the following conditions: Cannabis Use Disorder.
What interventions are being tested in trial NCT05885542?
The interventions under investigation include: Placebo (DRUG), Cannabidiol oral solution (DRUG).
Who is sponsoring clinical trial NCT05885542?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05885542 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cannabis Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05885542's enrollment target sits among peer trials
148 12th of 34 higher than 23 of 34 other Cannabis Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cannabis Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Psilocybin-assisted Treatment for Cannabis Use Disorder
RECRUITING · Phase 1
-
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use
RECRUITING · Phase 1
-
Mitigating PTSD-CUD After Sexual Assault
RECRUITING · Phase 1
-
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
RECRUITING · Phase 1
-
Integrated CBT for Cannabis Dependence With Co-occurring Anxiety Disorders
COMPLETED · Phase 1
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00739362 · 148 participants · Phase 2
Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment
- NCT03161223 · 148 participants · Phase 1
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
- NCT03858231 · 148 participants · Phase 4
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
- NCT04486352 · 148 participants · Phase 1
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI